HomeNewsBusinessCNBC-TV18 CommentsGilead ropes in Indian firms to promote cheaper HIV pills

Gilead ropes in Indian firms to promote cheaper HIV pills

US-based Gilead Sciences has roped in four Indian pharmaceutical companies to develop and market three new generic HIV/AIDS drugs in over 100 countries. The drugs are currently in final stages of clinical development. CNBC-TV18's Appaji Reddem and Ashwin Mohan delve deeper.

July 14, 2011 / 15:10 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

US-based Gilead Sciences has roped in four Indian pharmaceutical companies - Ranbaxy, Hetero Drugs, Matrix Labs, and Strides to develop and market three new generic HIV/AIDS drugs in over 100 countries. The drugs are currently in final stages of clinical development. CNBC-TV18

first published: Jul 12, 2011 09:45 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!